The Persona Knee system. [Image courtesy of Zimmer Biomet] Zimmer Biomet (NYSE: ZBH) + announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur. The revision ...

The device company generated revenues of $7.7bn in 2024, up 3.8% from 2023. Zimmer Biomet offers a range of orthopaedic implants and robotic technologies for joint replacement. Areas of the body ...

March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings ... clearance of Persona® Revision SoluTion™ Femur, a revision knee implant component offering an alternative for patients with ...

A Revision Knee Implant Alternative for Patients with Metal Sensitivities WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology ...

Weak demand, ERP system disruptions, and market share losses in hip implants have propelled the stock downward over the past year. On Feb. 6, Zimmer Biomet reported its Q4 and full-year 2024 results.

The North Korean threat actor known as the Lazarus Group has been linked to a previously undocumented JavaScript implant named Marstech1 as part of limited targeted attacks against developers. The ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Yasmin Ghahremani is a full-time Associate Editorial Director at Investopedia ...